OTC - ACTIVE INGREDIENT SECTION
Cimicifuga 100X (HPUS)
Formic Acid 100X (HPUS)
Gnaphalium 100X (HPUS)
Colocynthis 100X (HPUS)
Ranunculus Bulb 100X (HPUS)
Ledum Pal 100X (HPUS)
Cimicifuga 100X (HPUS)
Formic Acid 100X (HPUS)
Gnaphalium 100X (HPUS)
Colocynthis 100X (HPUS)
Ranunculus Bulb 100X (HPUS)
Ledum Pal 100X (HPUS)
Indications:
For detail please read the enclosed
package (Product information leaflet).
Indications:
For detail please read the enclosed
package (Product information leaflet).
Dosage:
10-15 drops, 3-4 times a day in
some water.
Precautions/storage:
Keep away from children and store
at cool and dry place.
Precautions/storage:
Keep away from children and store
at cool and dry place.
Alcohol
Package 1
Package 2
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 85816-2203 | 85816-2203-1, 85816-2203-2 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| RANUNCULUS BULBOSUS WHOLE | AEQ8NXJ0MB | ACTIB |
| ALCOHOL | 3K9958V90M | IACT |
| BLACK COHOSH | K73E24S6X9 | ACTIB |
| CITRULLUS COLOCYNTHIS FRUIT PULP | 23H32AOH17 | ACTIB |
| PSEUDOGNAPHALIUM OBTUSIFOLIUM WHOLE | 36XQ854NWW | ACTIB |
| FORMIC ACID | 0YIW783RG1 | ACTIB |
| RHODODENDRON TOMENTOSUM LEAFY TWIG | 877L01IZ0P | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BM BM203 DROPS | CIMICIFUGA, FORMIC ACID, GNAPHALIUM, COLOCYNTHIS, RANUNCULUS BULB, LEDUM PAL | BM Private Limited | 540de484-daac-d43c-e063-6294a90a784f | 2026-06-12 | Warnings | 85816-2203-2 85816-2203-1 85816-2203 85816220302 85816220301 540dcfc9-842e-ce9c-e063-6294a90a19b0 540de484-daac-d43c-e063-6294a90a784f |
Adverse event summaries are temporarily unavailable. Other product information remains available.